Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betsy Bove

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Molecular Diagnostics : JMD|May 19, 2025
Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Consensus Conference: Report from the Laboratory Challenges Working GroupVictoria M Pratt, Betsy Bove, Raymond A Lorenz, et al.
Genes, Chromosomes & Cancer|September 28, 2002
DNA array-based method for detection of large rearrangements in the BRCA1 geneAndrey Frolov, Amanda H Prowse, Lisa Vanderveer, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 22, 2003
Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experienceJosephine Wagner Costalas, Mark Itzen, John Malick, et al.
Archives of Pathology & Laboratory Medicine|November 21, 2025
Pharmacogenomic TestingYuan Ji, Lindsey Brunk, Betsy Bove, et al.
Human Mutation|July 12, 2002
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutationsIrene L Andrulis, Hoda Anton-Culver, Jeanne Beck, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
Human Mutation|July 4, 2012
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target siteBrooke L Brewster, Francesca Rossiello, Juliet D French, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Molecular Diagnostics : JMD|May 19, 2025
Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Consensus Conference: Report from the Laboratory Challenges Working GroupVictoria M Pratt, Betsy Bove, Raymond A Lorenz, et al.
Genes, Chromosomes & Cancer|September 28, 2002
DNA array-based method for detection of large rearrangements in the BRCA1 geneAndrey Frolov, Amanda H Prowse, Lisa Vanderveer, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 22, 2003
Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experienceJosephine Wagner Costalas, Mark Itzen, John Malick, et al.
Archives of Pathology & Laboratory Medicine|November 21, 2025
Pharmacogenomic TestingYuan Ji, Lindsey Brunk, Betsy Bove, et al.
Human Mutation|July 12, 2002
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutationsIrene L Andrulis, Hoda Anton-Culver, Jeanne Beck, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
Human Mutation|July 4, 2012
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target siteBrooke L Brewster, Francesca Rossiello, Juliet D French, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 1